The Impact of Red Blood Cell Distribution Width and Neutrophil/Lymphocyte Ratio on the Diagnosis of Major Depressive Disorder

被引：104

作者：

Demircan F. ^{[1
]}

Gözel N. ^{[2
]}

Kılınç F. ^{[3
]}

Ulu R. ^{[4
]}

Atmaca M. ^{[5
]}

机构：

[1] Department of Internal Medicine, Private Etic Life Medical Center, Istanbul

[2] Department of Internal Medicine, Firat Medical Faculty, Elazig

[3] Department of Internal Medicine, Dicle University Medical Faculty, Diyarbakir

[4] Department of Nephrology, Firat Medical Faculty, Elazig

[5] Department of Psychiatry, Firat Medical Faculty, Elazig

来源：

Neurology and Therapy | 2016年 / 5卷 / 1期

关键词：

Coronary artery disease; Major depressive disorder; Mean platelet volume; Neutrophil/lymphocyte ratio; Red cell distribution width;

D O I：

10.1007/s40120-015-0039-8

中图分类号：

学科分类号：

摘要：

Introduction: Major depressive disorder (MDD) is an important risk factor for cardiovascular mortality and morbidity. Red blood cell distribution width (RDW) and neutrophil/lymphocyte ratio (NLR) can be obtained with a basic hemogram test. These parameters have been found as a predictor of mortality in the general population and in several diseases such as cardiovascular disease. Methods: Our study included 100 patients with newly diagnosed MDD and 100 healthy control patients (who had no depressive symptoms and without heart disease) admitted to our outpatient clinics. Patients with MDD were started on selective serotonin reuptake inhibitor (SSRI) treatment and followed up for 3 months. Both MDD and control patients’ laboratory tests and physical, neurological, and psychiatric examinations were performed both at diagnosis and after 3 months of treatment. Results: In total, 100 patients with MDD were evaluated and 80 were included in our study. The control group consisted of 91 healthy individuals. The mean age was 44 ± 10.6 years for patients with MDD and 39.8 ± 11.4 years for the control group. There was no significant difference between the age for groups (P = 0.13); 55% of patients with MDD and 33% of the control group was male. NLR levels were found to be 2.55 ± 0.7 and RDW levels were found to be 14.3 ± 2.6 in patients with MDD; NLR levels were found to be 1.41 ± 0.8 and RDW levels were found to be 13.4 ± 1.8 in the control group. RDW and NLR levels were significantly higher in patients with MDD compared to the control group. The significant difference between the levels of RDW and NLR in patients with MDD and the control group was dissolved after SSRI treatment (P < 0.001). RDW [median 14.3, interquartile range (IQR) 2.8 vs. median 13.25, IQR 2.45; P < 0.001] and NLR (median 2.3, IQR 1.1 vs. median 2.0, IQR 1.15; P < 0.001) levels were significantly higher in patients with MDD compared to the control group. Conclusion: Our study showed that hematological inflammatory markers might be useful parameters that can be used in patients with MDD for coronary artery disease risk. Specifically, RDW and NLR seem to be more hopeful. Advanced, detailed, and larger studies are needed. © 2015, The Author(s).

引用

页码：27 / 33

页数：6

共 22 条

[1]

Frasure-Smith N., Lesperance F., Talajic M., Depression following myocardial infarction. Impact on 6-month survival, JAMA, 270, pp. 1819-1825, (1993)

[2]

Bush D.E., Ziegelstein R.C., Tayback M., Richter D., Stevens S., Zahalsky H., Fauerbach J.A., Even minimal symptoms of depression increase mortality risk after acute myocardial infarction, Am J Cardiol, 88, pp. 337-341, (2001)

[3]

Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W., Depression and cardiac mortality: results from a community-based longitudinal study, Arch Gen Psychiatry, 58, pp. 221-227, (2001)

[4]

Parissis J.T., Fountoulaki K., Filippatos G., Adamopoulos S., Paraskevaidis I., Kremastinos D., Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications, Int J Cardiol, 116, pp. 153-160, (2007)

[5]

Nemeroff C.B., Musselman D.L., Are platelets the link between depression and ischemic heart disease?, Am Heart J, 140, pp. 57-62, (2000)

[6]

Markovitz J.H., Matthews K.A., Platelets and coronary heart disease: potential psychophysiologic mechanisms, Psychosom Med, 53, pp. 643-668, (1991)

[7]

Morgan D.L., Peck S.D., The use of red cell distribution width in the detection of iron deficiency in chronic hemodialysis patients, Am J Clin Pathol, 89, 4, pp. 513-515, (1988)

[8]

Zalawadiya S.K., Veeranna V., Panaich S.S., Afonso L., Ghali J.K., Gender and ethnic differences in red cell distribution width and its association with mortality among low risk healthy United State adults, Am J Cardiol, 109, 11, pp. 1664-1670, (2012)

[9]

van Kimmenade R.R.J., Mohammed A.A., Uthamalingam S., Van DerMeer P., Felker G.M., Januzzi J.L., Red blood cell distribution width and 1-year mortality in acute heart failure, Eur J Heart Fail., 12, 2, pp. 129-136, (2010)

[10]

Al-Najjar Y., Goode K.M., Zhang J., Cleland J.G.F., Clark A.L., Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure, Eur J Heart Fail, 11, 12, pp. 1155-1162, (2009)

← 1 2 3 →